Health Catalyst, Inc. <HCAT.O>: Wells Fargo cuts target price to $1.5 from $1.75
HCAT•Related News
McGraw Hill Fiscal Q1 2027 Total Revenue $549.90 Million, Up 2.6% Year-Over-Year - SEC Filing
MH•
Pelthos Therapeutics Financial Statements Should No Longer Be Relied Upon For Quarter Ended March 31- SEC Filing
PTHS•
Alliance Laundry Reports Second Quarter 2026 Results
ALH•
ADC Therapeutics Q2 FY26 net loss narrows 70.75% to $16.6 million; revenue rises 2.99% to $19.25 million
ADCT•
Abeona Therapeutics Q2 net loss widens, misses analyst expectations
ABEO•